Highmount Capital’s Ambev ABEV Stock Holding History

Highmount Capital’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-37,724	Closed	-$235K	–	133
2014 Q4	$235K	Sell	37,724 -42,276	-53%	-$267K	0.06%	126
2014 Q3	$524K	Buy	+80,000	New	+$563K	0.13%	94

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GTP

Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Highmount Capital's ABEV Position: Q1 2015 in Review

Highmount Capital sold out of Ambev (ABEV) in Q1 2015, closing a stake of 37,724 shares — an estimated $235K sold.

Highmount Capital first reported a position in ABEV in Q3 2014 and held it in 2 quarters. The position peaked at $524K in Q3 2014. 303 funds tracked by Wall St. Rank hold ABEV as of Q1 2015.

Highmount Capital reported no remaining Ambev position as of Q1 2015 after selling out during the quarter.
Highmount Capital sold 37,724 Ambev shares in Q1 2015, an estimated $235K.
Highmount Capital first reported a position in Ambev in Q3 2014 and held it in 2 quarters.
Highmount Capital's Ambev position peaked at $524K in Q3 2014.
303 funds tracked by Wall St. Rank held Ambev as of Q1 2015.

Based on Highmount Capital's 13F filing for Q1 2015, filed 15 May 2015.